Breyanzi
Researchers Showcase New Scores, Biomarkers, Signatures for Predicting CAR T-Cell Outcomes at ASH
Premium
Across three studies, researchers demonstrated how various biomarkers can inform trial design and predict lymphoma patients' outcomes on CAR T-cell therapy.